BioSpace News Archive

Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, announced today further details on the Material Transfer Agreement (MTA) signed with a leading public health-focused U.S. university and top coronavirus expert. Under the terms of the confidential agreement, virologists plan to evaluate the potential antiviral properties of Brilacidin, the Company’s lead defensin-mimetic drug candidate, t

Independent research suggests new approach to inhibiting the viral replication capability of a range of viruses, including Coronavirus

Nobio Ltd. and Supergum (1983) Ltd. today announced an agreement to rapidly prototype and test an antiviral protective mask, combining Nobio’s revolutionary antimicrobial technology and Supergum’s market leading CBRN (chemical, biological, radiological and nuclear) breathing protection products. Nobio’s

Eton Pharmaceuticals, Inc today announced positive bioequivalence study results for ET-101, its proprietary oral solution formulation of topiramate. A bioequivalen

Happiness Biotech Group Limited (the “Company” or Nasdaq: HAPP), an innovative China -based nutraceutical and dietary supplements producer, announced today that the Company has begun production of daily protective masks. Due to the shortage of melt-blown non-woven fabric (“Melt-blown Fabric”), the production capacity of masks i

Lee Brings Decades of Experience to the Team as the Demand for AI-Driven Analytics Solutions Accelerates

Health Catalyst, Inc. announced that, after dozens of conversations with health system clients, the company will initially be offering three COVID-19 Solutions to its domestic clients, with the first of these solutions becoming available to pilot clients by the end of March.

Post-Approval Study will evaluate real-world safety and efficacy evidence for breakthrough heart failure therapy

Partnership Aims to Accelerate NGS Adoption for Clinical Infectious Disease Testing by Combining Comprehensive Sequencing Workflows with Turn-key Clinical Informatics SAN FRANCISCO--( BUSINESS WIRE )-- IDbyDNA Inc., a metagenomics technology company setting a standard for detection, identification and interpretation of microorganisms and their role in human health, today announced a global strategic partnership with Illumina, Inc. (Nasdaq: ILM

aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, announced the appointment of Arthur M. Mercurio, Ph.D. as a scientific advisor to the company.